A New Model Of Venture Capital

BioAdvance is an evergreen fund where returns are redeployed into new investments. We don’t shy away from early stage science or early stage investing. We believe in the power of an entrepreneurial ecosystem. Our team works closely with entrepreneurs to build strong companies focused on human health.

36 Portfolio Companies and Counting

10 Exits, Most recently, Ceptaris
7 Products With FDA Approval